PTC Therapeutics
From Wikipedia, the free encyclopedia
PTC Therapeutics is a pharmaceutical company. It is headquartered in South Plainfield, New Jersey.
They are the company responsible for the development of PTC124.[1]
[edit] References
- ^ Hamed SA (2006). "Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy". IDrugs : the investigational drugs journal 9 (11): 783–9. PMID 17096300.
[edit] External links
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
